Cargando…
Dysregulation of type I interferon responses in COVID-19
Infection with SARS-CoV-2 can lead to excessive production of pro-inflammatory cytokines, but the production of type I interferons, which are key antiviral mediators, is reportedly blunted. Here, we discuss how imbalanced interferon responses may contribute to the pathology of COVID-19.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249038/ https://www.ncbi.nlm.nih.gov/pubmed/32457522 http://dx.doi.org/10.1038/s41577-020-0346-x |
_version_ | 1783538510881357824 |
---|---|
author | Acharya, Dhiraj Liu, GuanQun Gack, Michaela U. |
author_facet | Acharya, Dhiraj Liu, GuanQun Gack, Michaela U. |
author_sort | Acharya, Dhiraj |
collection | PubMed |
description | Infection with SARS-CoV-2 can lead to excessive production of pro-inflammatory cytokines, but the production of type I interferons, which are key antiviral mediators, is reportedly blunted. Here, we discuss how imbalanced interferon responses may contribute to the pathology of COVID-19. |
format | Online Article Text |
id | pubmed-7249038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72490382020-05-26 Dysregulation of type I interferon responses in COVID-19 Acharya, Dhiraj Liu, GuanQun Gack, Michaela U. Nat Rev Immunol Comment Infection with SARS-CoV-2 can lead to excessive production of pro-inflammatory cytokines, but the production of type I interferons, which are key antiviral mediators, is reportedly blunted. Here, we discuss how imbalanced interferon responses may contribute to the pathology of COVID-19. Nature Publishing Group UK 2020-05-26 2020 /pmc/articles/PMC7249038/ /pubmed/32457522 http://dx.doi.org/10.1038/s41577-020-0346-x Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Acharya, Dhiraj Liu, GuanQun Gack, Michaela U. Dysregulation of type I interferon responses in COVID-19 |
title | Dysregulation of type I interferon responses in COVID-19 |
title_full | Dysregulation of type I interferon responses in COVID-19 |
title_fullStr | Dysregulation of type I interferon responses in COVID-19 |
title_full_unstemmed | Dysregulation of type I interferon responses in COVID-19 |
title_short | Dysregulation of type I interferon responses in COVID-19 |
title_sort | dysregulation of type i interferon responses in covid-19 |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249038/ https://www.ncbi.nlm.nih.gov/pubmed/32457522 http://dx.doi.org/10.1038/s41577-020-0346-x |
work_keys_str_mv | AT acharyadhiraj dysregulationoftypeiinterferonresponsesincovid19 AT liuguanqun dysregulationoftypeiinterferonresponsesincovid19 AT gackmichaelau dysregulationoftypeiinterferonresponsesincovid19 |